journal article·2025-05Open access

Gd‐Layered Double Hydroxides for Magnetic Resonance Imaging and Curcumin Delivery for Ischemic Stroke

Miao Yu, Zhen Tian, Haimo Zhang, Yijing Wang, Xiaozu Zhang, Yuxue Luan, Peilun Xiao, Xiaoli Wang

ChemNanoMat· Volume 11· Issue 5

Abstract

Herein, layered double hydroxides (LDHs) with varying gadolinium (Gd) content are synthesized using coprecipitation method and characterized by X‐ray diffraction, scanning electron microscopy, Fourier transform infrared spectroscopy, and magnetic resonance imaging. Gd 0.1 ‐LDHs exhibit characteristic diffraction peaks of LDHs and consist of ≈100 nm nanosheets (measured using Nano Measurer software), with a chemical composition of Mg 0.73 Al 0.25 Gd 0.022 (OH) 2 (NO 3 ) 0.12 (CO 3 ) 0.075 ·0.8H 2 O. MRI results reveal the longitudinal relaxivity ( r 1 ) of Gd 0.1 ‐LDHs and Gd 0.5 ‐LDHs is 2.52 and 0.84 mM −1 S −1 , respectively, which can be attributed to magnetic coupling effects. Curcumin (CUR) is loaded on Gd 0.1 ‐LDHs, forming Gd 0.1 ‐LDHs/CUR with a loading capacity of 14%. The release of CUR is pH‐sensitive and follows a pseudo‐second‐order model, controlled by a diffusion process, with intraparticle diffusion as the rate‐limiting step. Furthermore, the cytotoxicity of Gd 0.1 ‐LDHs/CUR is evaluated using PC12 cells, the cell viability exceeds 100% even at a high concentration of 100 μg mL −1 , confirming its excellent biocompatibility. Additionally, in vitro experiments show that Gd 0.1 ‐LDHs/CUR improves the cell viability of PC12 cells following oxygen and glucose deprivation from 75.3% to 88.3%, indicating its potential to alleviate cellular damage. This study presents a novel approach to developing nanoprobes for diagnosing and treating cerebral ischemia‐reperfusion injury.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Polyoxometalates: Synthesis and Applications · Metal-Organic Frameworks: Synthesis and Applications · Layered Double Hydroxides Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Medical Imaging Shandong Second Medical University Weifang 261053 P. R. China

Department of Science and Technology Quality Weifang CEPREI Industrial Technology Research Institute Co., Ltd. Weifang 261061 P. R. China

School of Basic Medicine Shandong Second Medical University Weifang 261053 P. R. China

Funding

National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.1177/1747493021106591710.1177/17474930211065917 ↗
2. 10.1212/WNL.000000000001278110.1212/WNL.0000000000012781 ↗
3. 10.1007/s12264-022-00859-010.1007/s12264-022-00859-0 ↗
4. 10.1007/s12975-022-01100-w10.1007/s12975-022-01100-w ↗
5. 10.1016/j.foodchem.2023.13646410.1016/j.foodchem.2023.136464 ↗
6. 10.1016/j.canlet.2023.21633210.1016/j.canlet.2023.216332 ↗
7. 10.1021/acschemneuro.1c0015310.1021/acschemneuro.1c00153 ↗
8. 10.1007/s10495-023-01869-710.1007/s10495-023-01869-7 ↗
9. 10.1186/s12974-023-02738-510.1186/s12974-023-02738-5 ↗
10. 10.3390/pharmaceutics1310171510.3390/pharmaceutics13101715 ↗
11. 10.1002/advs.20230603510.1002/advs.202306035 ↗
12. 10.1016/j.ccr.2024.21583210.1016/j.ccr.2024.215832 ↗
13. 10.1515/ntrev-2014-001810.1515/ntrev-2014-0018 ↗
14. 10.1016/j.addr.2022.11459010.1016/j.addr.2022.114590 ↗
15. 10.1021/acsami.1c1653010.1021/acsami.1c16530 ↗
16. 10.1016/j.nicl.2022.10304410.1016/j.nicl.2022.103044 ↗
17. 10.1021/jacs.9b0914910.1021/jacs.9b09149 ↗
18. 10.1007/s00204-021-03189-810.1007/s00204-021-03189-8 ↗
19. 10.1016/j.ejro.2023.10050310.1016/j.ejro.2023.100503 ↗
20. 10.1016/j.apmt.2024.10208710.1016/j.apmt.2024.102087 ↗
21. 10.3390/nano910140410.3390/nano9101404 ↗
22. 10.1016/j.jallcom.2021.15962810.1016/j.jallcom.2021.159628 ↗
23. 10.1016/j.apsusc.2021.14957710.1016/j.apsusc.2021.149577 ↗
24. 10.1016/j.clay.2013.05.01510.1016/j.clay.2013.05.015 ↗
25. 10.1016/j.colsurfa.2020.12507810.1016/j.colsurfa.2020.125078 ↗
26. 10.1016/j.clay.2020.10555610.1016/j.clay.2020.105556 ↗
27. 10.1038/s41467-022-31106-910.1038/s41467-022-31106-9 ↗
28. 10.1002/adfm.20220352010.1002/adfm.202203520 ↗
29. 10.1021/acsami.1c1957310.1021/acsami.1c19573 ↗
30. 10.1002/smll.20220385210.1002/smll.202203852 ↗
31. 10.1016/j.eti.2022.10237710.1016/j.eti.2022.102377 ↗
32. 10.1016/j.optmat.2022.11263610.1016/j.optmat.2022.112636 ↗
33. 10.1016/j.carbpol.2021.11908010.1016/j.carbpol.2021.119080 ↗
34. 10.1557/s43578-023-00970-610.1557/s43578-023-00970-6 ↗
35. 10.1166/jbn.2016.229110.1166/jbn.2016.2291 ↗
36. 10.1016/j.clay.2020.10589110.1016/j.clay.2020.105891 ↗
37. 10.1111/jphp.1326610.1111/jphp.13266 ↗
38. 10.1016/j.clay.2007.07.00810.1016/j.clay.2007.07.008 ↗
39. 10.1007/s10853-010-4423-610.1007/s10853-010-4423-6 ↗
40. Lisevski C. I. · ACS Omega · 2024 · 9 · 32962
41. 10.1016/j.bioactmat.2022.05.01210.1016/j.bioactmat.2022.05.012 ↗
42. 10.1039/D2NH00478J10.1039/D2NH00478J ↗
43. 10.1039/D2SM01084D10.1039/D2SM01084D ↗
44. 10.1039/C5RA15888E10.1039/C5RA15888E ↗
45. 10.3390/cryst1004024410.3390/cryst10040244 ↗
46. 10.1007/s00289-021-03761-310.1007/s00289-021-03761-3 ↗
47. 10.1016/j.jpcs.2017.04.01810.1016/j.jpcs.2017.04.018 ↗
48. 10.1021/acs.inorgchem.9b0275610.1021/acs.inorgchem.9b02756 ↗
49. 10.1021/acs.inorgchem.2c0074310.1021/acs.inorgchem.2c00743 ↗
50. 10.1002/fsn3.306210.1002/fsn3.3062 ↗